about
Reported rates of diarrhea following oral penicillin therapy in pediatric clinical trialsPandemic influenza A H1N1 vaccines and narcolepsy: vaccine safety surveillance in action.Sex-dependent immune responses to infant vaccination: an individual participant data meta-analysis of antibody and memory B cells.Pharmacokinetic/pharmacodynamic modelling approaches in paediatric infectious diseases and immunologyAntibiotic dosing in children in Europe: can we grade the evidence from pharmacokinetic/pharmacodynamic studies - and when is enough data enough?Improving antibiotic prescribing for children in the resource-poor setting.The roles of clinical pharmacologists in formulating medicines policy locallyAugmented renal clearance implies a need for increased amoxicillin-clavulanic acid dosing in critically ill children.The seroepidemiology of Haemophilus influenzae type b prior to introduction of an immunization programme in Kathmandu, Nepal.Oral penicillin prescribing for children in the UK: a comparison with BNF for Children age-band recommendations.What do I need to know about aminoglycoside antibiotics?What do I need to know about penicillin antibiotics?Not too little, not too much: problems of selecting oral antibiotic dose for children.Did the accuracy of oral amoxicillin dosing of children improve after British National Formulary dose revisions in 2014? National cross-sectional survey in England.Development of a Novel Multipenicillin Assay and Assessment of the Impact of Analyte Degradation: Lessons for Scavenged Sampling in Antimicrobial Pharmacokinetic Study Design.Selected national pharmacovigilance websites: an analysis of contents.Pharmacokinetic-Pharmacodynamic Modeling in Pediatric Drug Development, and the Importance of Standardized Scaling of Clearance.Pharmacokinetic studies in children: recommendations for practice and research.Useful pharmacodynamic endpoints in children: selection, measurement, and next steps.Scaling beta-lactam antimicrobial pharmacokinetics from early life to old ageGAPPS (Grading and Assessment of Pharmacokinetic-Pharmacodynamic Studies) a critical appraisal system for antimicrobial PKPD studies - development and application in pediatric antibiotic studiesEarly origins of oral penicillin dosing for children
P50
Q28083234-8A4CA9AF-6669-4A62-A517-09B9C07ACB44Q30357127-9D676EEC-FBB9-4CEE-9650-3A624AF4BCD1Q31049522-3DAF8598-2E1F-47B2-BD96-BE4445014B7FQ33827819-EEDE9FBE-D042-45B1-8142-1BB8467FC5F5Q34239948-C641B98F-5198-44BC-A09D-5FAAC1480B0AQ35135959-07070937-0D82-4627-8941-964067952FB2Q36081477-038C735A-F273-4CD4-B98E-DF6D17AFF52DQ36158484-7E4E5110-2D83-4759-8F9B-D17FB24CA0CBQ37504676-77AB4431-173A-43D6-BE2D-0B2AD0452C85Q37660847-63753E2D-2902-4751-9E37-86F9254031E8Q38923109-149EA5BC-A5D2-4155-BD35-F00EE3152C22Q40614682-84BBBE5E-DCAB-4F73-B6B5-754900FB0B4FQ40922727-00F119D2-1FE4-4D4C-8ACD-C20812BA97FFQ41956994-CC2E889E-167E-4122-A915-98A59898752AQ47689223-1840A594-E455-442B-99B0-1155FEFBBEAAQ50153392-FA8D6C04-2B94-4A0B-B9BC-40A21C53445CQ52575612-41F21410-55DF-4612-A242-D31BE4148562Q52576551-E26F7C08-029F-410A-839B-9D6AF3F46D5BQ55360869-5D148C0E-BCF6-46DE-9A91-BA66CC758F28Q59263334-65F15347-4C43-4282-BD33-88FF88734259Q91355956-D50A9832-4205-450C-8486-F674AD908F66Q93161227-6B34524D-14A0-4042-A005-42E02FC5E9AB
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Charlotte I Barker
@ast
Charlotte I Barker
@en
Charlotte I Barker
@es
Charlotte I Barker
@nl
Charlotte I Barker
@sl
type
label
Charlotte I Barker
@ast
Charlotte I Barker
@en
Charlotte I Barker
@es
Charlotte I Barker
@nl
Charlotte I Barker
@sl
prefLabel
Charlotte I Barker
@ast
Charlotte I Barker
@en
Charlotte I Barker
@es
Charlotte I Barker
@nl
Charlotte I Barker
@sl
P106
P21
P31
P496
0000-0002-6757-5867